Daytime sleep in Parkinson's disease measured by episodes of immobility

Parkinsonism and Related Disorders

Volumn 20, Issue 6, 2014, Pages 578-583

  Kotschet, K ^a,b   Johnson, W ^b   McGregor, S ^b   Kettlewell, J ^a   Kyoong, A ^b   O'Driscoll, D M ^c,d   Turton, A R ^e   Griffiths, R I ^a   Horne, M K ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c Department of Respiratory and Sleep Medicine Eastern Health ^*  (Australia)

^d MONASH UNIVERSITY   (Australia)

^e SOUTHERN HEALTH   (Australia)

Author keywords

Actigraphy; Automated analysis; Bradykinesia; Day time sleepiness; Parkinson's; Sleep

Indexed keywords

LEVODOPA;

ACTIMETRY; ADULT; AGED; ARTICLE; BRADYKINESIA; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE DURATION; DYSKINESIA; EPWORTH SLEEPINESS SCALE; HUMAN; IMMOBILITY; MAJOR CLINICAL STUDY; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; UNIFIED PARKINSON DISEASE RATING SCALE; ACCELEROMETRY; COMPLICATION; DISORDERS OF EXCESSIVE SOMNOLENCE; DYSKINESIAS; FEMALE; HYPOKINESIA; IMMOBILIZATION; MALE; MIDDLE AGED; VERY ELDERLY;

ACCELEROMETRY; ADULT; AGED; AGED, 80 AND OVER; DISORDERS OF EXCESSIVE SOMNOLENCE; DYSKINESIAS; FEMALE; HUMANS; HYPOKINESIA; IMMOBILIZATION; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYSOMNOGRAPHY;

EID: 84900012302     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.02.011     Document Type: Article

References (34)

1. Tan E.K., Lum S.Y., Fook-Chong S.M., Teoh M.L., Yih Y., Tan L., et al. Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls. Neurology 2002, 58:465-468.
2. Lees A.J., Blackburn N.A., Campbell V.L. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988, 11:512-519.
3. Ondo W.G., Dat Vuong K., Khan H., Atassi F., Kwak C., Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 2001, 57:1392-1396.
4. Arnulf I., Leu-Semenescu S. Sleepiness in Parkinson's disease. Parkinsonism Relat Disord 2009, 15(Suppl. 3):S101-S104.
5. Arnulf I. Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 2005, 9:185-200.
6. Johns M.W. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 2000, 9:5-11.
7. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
8. Bliwise D.L., Trotti L.M., Wilson A.G., Greer S.A., Wood-Siverio C., Juncos J.J., et al. Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class. Mov Disord 2012, 27:1118-1124.
9. Frucht S., Rogers J.D., Greene P.E., Gordon M.F., Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999, 52:1908-1910.
10. Ferreira J.J., Thalamas C., Montastruc J.L., Castro-Caldas A., Rascol O. Levodopa monotherapy can induce "sleep attacks" in Parkinson's disease patients. J Neurol 2001, 248:426-427.
11. Pal S., Bhattacharya K.F., Agapito C., Chaudhuri K.R. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm 2001, 108:71-77.
12. Olanow C.W., Schapira A.H., Roth T. Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole. Neurology 2000, 54:274. [author reply 6-7].
13. Gasser T., Schwarz J., Arnold G., Trenkwalder C., Oertel W.H. Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease. Arch Neurol 1992, 49:1131-1134.
14. Razmy A., Lang A.E., Shapiro C.M. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004, 61:97-102.
15. Poryazova R., Benninger D., Waldvogel D., Bassetti C.L. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants. Eur Neurol 2010, 63:129-135.
16. Hobson D.E., Lang A.E., Martin W.R., Razmy A., Rivest J., Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. J Am Med Assoc 2002, 287:455-463.
17. Rye D.B., Bliwise D.L., Dihenia B., Gurecki P. Daytime sleepiness in Parkinson's disease. J Sleep Res 2000, 9:63-69.
18. Arnulf I., Konofal E., Merino-Andreu M., Houeto J.L., Mesnage V., Welter M.L., et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002, 58:1019-1024.
19. Valko P.O., Waldvogel D., Weller M., Bassetti C.L., Held U., Baumann C.R. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol Off J Eur Fed Neurol Soc 2010, 17:1428-1436.
20. Arnulf I., Bonnet A.M., Damier P., Bejjani B.P., Seilhean D., Derenne J.P., et al. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 2000, 55:281-288.
21. Merino-Andreu M., Arnulf I., Konofal E., Derenne J.P., Agid Y. Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness. Neurology 2003, 60:1553-1554.
22. Shpirer I., Miniovitz A., Klein C., Goldstein R., Prokhorov T., Theitler J., et al. Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study. Mov Disord 2006, 21:1432-1438.
23. Stavitsky K., Saurman J.L., McNamara P., Cronin-Golomb A. Sleep in Parkinson's disease: a comparison of actigraphy and subjective measures. Parkinsonism Relat Disord 2010, 16:280-283.
24. Griffiths R.I., Kotschet K., Arfon S., Xu Z.M., Johnson W., Drago J., et al. Automated assessment of bradykinesia and dyskinesia in Parkinson's disease. J Parkinsons Dis 2012, 2:47-55.
25. Jean-Louis G., Zizi F., von Gizycki H., Hauri P. Actigraphic assessment of sleep in insomnia: application of the Actigraph Data Analysis Software (ADAS). Physiol Behavior 1999, 65:659-663.
26. Australian Sleep Association ASTA/ASA Commentary on AASM Manual for the scoring of sleep and associated events 2010, Available from:. http://www.sleep.org.au/information/sleep-documents/astaasa-commentary-on-aasm-manual-for-scoring-of-sleep-associated-events-december-2010.
27. Frucht S.J., Greene P.E., Fahn S. Sleep episodes in Parkinson's disease: a wake-up call. Mov Disord 2000, 15:601-603.
28. Rye D.B., Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 2002, 58:341-346.
29. Rye D.B. The two faces of Eve: dopamine's modulation of wakefulness and sleep. Neurology 2004, 63:S2-S7.
30. Monti J.M., Jantos H. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog Brain Res 2008, 172:625-646.
31. Wienecke M., Werth E., Poryazova R., Baumann-Vogel H., Bassetti C.L., Weller M., et al. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?. J Sleep Res 2012, 21:710-717.
32. Bliwise D.L., Trotti L.M., Juncos J.J., Factor S.A., Freeman A., Rye D.B. Daytime REM sleep in Parkinson's disease. Parkinsonism Relat Disord 2013, 19:101-103.
33. Iranzo A. Sleep-wake changes in the premotor stage of Parkinson disease. J Neurol Sci 2011, 310:283-285.
34. Li Y., van den Pol A.N. Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J Neurosci 2005, 25:173-183.